LDHA and glioblastoma: Since GBM tumor cells predominantly rely on aerobic glycolysis, targeting key enzymes, such as HK2 [32] and LDH isoforms (LDHA and LDHB) [33,34], to disrupt glycolytic pathways holds therapeutic potential.